Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Disease Models & Mechanisms|April 7, 2017
Waging war against pancreatic cancer: an interview with David TuvesonDavid Tuveson
Science (New York, N.Y.)|June 8, 2019
Cancer modeling meets human organoid technologyDavid Tuveson, Hans Clevers
Cold Spring Harbor Perspectives in Medicine|January 10, 2018
Kras in OrganoidsDerek Cheng, David Tuveson
The Journal of Experimental Medicine|July 30, 2014
Fibroblast heterogeneity in the cancer woundDaniel Öhlund, Ela Elyada, David Tuveson
Expert Opinion on Drug Metabolism & Toxicology|June 27, 2019
Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancerRyan Sugarman, Rajvi Patel, Sandhya Sharma, et al.
Gut|June 6, 2020
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case seriesTobias Janowitz, Eva Gablenz, David Pattinson, et al.
Cancer Cell|October 21, 2020
Impact of COVID-19 Pandemic on Cancer ResearchLeonard Zon, Ana P Gomes, William G Cance, et al.
Oncogene|June 30, 2019
Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cellsPaul Dent, Laurence Booth, Jane L Roberts, et al.
The Journal of Experimental Medicine|October 15, 2020
Immigration in scienceJean-Laurent Casanova, David M Holtzman, Susan M Kaech, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 21, 2018
Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug ScreeningShurong Hou, Hervé Tiriac, Banu Priya Sridharan, et al.
Pageof 3